Dr. Cohen is Coordinator of Interprofessional Education and Continuing Professional Education and Professor of Pharmacotherapy at the University of North Texas. He currently serves and President of the Faculty Senate. Dr. Cohen is Emeritus Professor of Pharmacotherapy at Washington State University College of Pharmacy in Spokane, and previously also served as Department Chairman. He also served as Professor for WIMHRT (Washington Institute for Mental Health Research and Training) and previously served as Assistant Director for Psychopharmacology Research and Training. At WSU, Dr. Cohen worked with graduate students and faculty and was Professor of Health Policy and Administration for WSU–Spokane. Previously, Dr. Cohen was Professor of Psychiatry, Medicine and Clinical Pharmacy at the University of Cincinnati Colleges of Medicine and Pharmacy. Dr. Cohen has also served as Director of the Office of Clinical Trials for the University of Cincinnati. Prior to his appointment at the University of Cincinnati, Dr. Cohen was Global Director of Central Nervous System Research for Kendle International Inc, one of the largest global clinical research organizations. Prior to moving to Cincinnati, Dr. Cohen was Professor of Pharmacy, Psychiatry + Behavioral Sciences at the University of Oklahoma Colleges of Pharmacy and Medicine, and Director of Clinical Pharmacology Services for the Developmental Disabilities Services Division of the Oklahoma Department of Human Services, where he provided patient clinical consultations on a statewide basis, educational programs for professional staff and the public and technical assistance to the Department regarding policy and program development. Dr. Cohen also served as the Director of Pharmaceutical Services for the Oklahoma Department of Mental Health and Substance Abuse Services and was responsible for pharmacy services for all State Hospitals and Community Mental Health Centers Pharmacy Services throughout the state and chaired the Department’s Statewide Pharmacy & Therapeutics Committee. Dr. Cohen has also held academic appointments at the University of California, San Francisco School of Pharmacy and University of Maryland School of Pharmacy.
Dr. Cohen has been elected Fellow of the American College of Clinical Pharmacy, the American Society of Health-System Pharmacists and American College of Clinical Pharmacology. Dr. Cohen was recently elected to the Board of Regents of the American College of Clinical Pharmacology and has also served as Chair of the 2013-14 Education Committee, member of the 2013 Program Committee, reviewer for the Journal of Clinical Pharmacology and as an Annual Meeting Poster Reviewer. Dr. Cohen is a Founding Director of the College of Psychiatric and Neurologic Pharmacists. Dr. Cohen is a member of many professional organizations including the American College of Clinical Pharmacy, where he founded and served as Chairman of the Central Nervous System Practice and Research Network, was elected to the Board of Regents and most recently served as President. He also served the membership of the American Society of Health-System Pharmacists, as Chairman of the Psychopharmacy Specialty Practice Group and various committees and task forces. In March 2010, Dr. Cohen was inducted as a Distinguished Practitioner and Fellow of the National Academies of Practice (Pharmacy Academy). Dr. Cohen is a Board Certified Psychiatric Pharmacist has served as a member of the Board of Pharmaceutical Specialties Psychiatric Pharmacy Specialty Council. He served as a member of the United States Pharmacopeia Psychiatry Expert Committee from 2005-1010 where he participated in development the Model Guidelines for CMS.
Dr. Cohen's scholarly interests include pharmacokinetics and pharmacodynamics of psychotropic medications, geriatric psychopharmacology, pharmacoeconomics and health outcomes, pharmacoepidemiology, and emergency preparedness (specifically, access to healthcare during times of crisis). He has served as consultant for numerous pharmaceutical companies and national managed-care organizations. He has served on the Editorial Boards of Current Psychiatry, Innovations in Clinical Neuroscience, Psychiatry 2010, the Primary Care Companion of the Journal of Clinical Psychiatry, Drug Benefit Trends, the Journal of the American Medical Directors Association, CNS News and Pharmacy Practice News, and as a reviewer for journals such as Journal of Clinical Psychiatry, Pharmacotherapy, Annals of General Psychiatry, Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, Journal of Clinical Pharmacology, Human Psychopharmacology: Clinical and Experimental, Clinical Therapeutics, Current Psychiatry, Pharmacoeconomics, and American Pharmacy. He also has fulfilled an extensive invited lecture schedule and has both authored and co-authored numerous articles in professional journals.
After earning his Doctor of Pharmacy degree at the University of Southern California School of Pharmacy, he completed his postdoctoral residency in psychiatric pharmacy at the LA County/USC Medical Center. Throughout his professional career, Dr. Cohen has been recognized for his clinical skills, management abilities and professional activities.